HotSpot Therapeutics
Boston
About HotSpot Therapeutics
HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases. HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $210.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2021)
- Website: hotspotthera.com
- Phone: 617-758-8998
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/hotspot-therapeutics-17027 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.